A peptide is a chain of 2 to 40 amino acids, the same units that make up the protein in your food. Most peptide drugs work by binding a receptor on the outside of a cell, and most have to be injected because the gut digests them before they can reach the blood.
Your body uses 20 standard amino acids. Each has the same backbone and a different side chain. Link two of them and a molecule of water comes off; the bond left behind is a peptide bond.
Every chain has a direction. One end carries a free amino group (the N-terminus), the other a free carboxyl group (the C-terminus). Sequences are written from the N-terminus, one letter per amino acid. Oxytocin is CYIQNCPLG. BPC-157 is GEPPPGKPADDAGLV.
The side chains decide what the peptide does. Some carry a positive or negative charge, some repel water, and some can link to each other. Oxytocin's two cysteines (the C's) bond together and close the chain into a ring.
Tap a molecule to see where it sits. Peptides fill the gap between pill-sized drugs and the large proteins grown in cells, and that middle size explains most of their behavior.
A modified copy of the gut hormone GLP-1. The amino acid at position 8 is swapped so the enzyme DPP-4 cannot cut it, and a fatty acid chain makes it stick to albumin in the blood. Together they stretch its half-life from minutes to about a week.
Weights are average molecular masses from the product labels and PubChem. In bremelanotide, X stands for norleucine, an amino acid not found in human proteins. The 40-amino-acid line is the FDA definition in 21 CFR 600.3(h)(6).
Step through the five stages, using the GLP-1 drugs as the example. The same pattern applies to most peptide hormones and the research peptides built from them.
After an injection, the peptide moves from the fat under the skin into the blood and circulates until it meets a cell that carries its receptor. Cells without that receptor ignore it.
Digesting peptide bonds is the job your stomach and small intestine do for every meal. A peptide drug swallowed as a plain capsule meets the same fate as a bite of chicken.
Acid at pH 1.5 to 3.5 unfolds the chain, and the enzyme pepsin starts cutting it.
Trypsin, chymotrypsin and other enzymes from the pancreas cut what is left into fragments and single amino acids.
Cells lining the gut are sealed together. Molecules much larger than about 500 Da barely get through.
Whatever is absorbed passes through the liver before reaching the rest of the body.
An injection under the skin skips all four. About 89% of an injected semaglutide dose reaches the blood, compared with roughly 0.4 to 1% from the tablet.
Bars use a log scale. Values from the product labels and Holst (2007).
Mixed with SNAC, a chemical that briefly raises the pH around the tablet in the stomach and helps the peptide cross the stomach lining.
An 11-amino-acid ring peptide used after organ transplants. Its ring shape and fatty side chains let enough of it survive the gut to work as a capsule.
Works inside the gut on the intestinal lining, so it never needs to be absorbed into the blood.
A small modified vasopressin given as a nasal spray or tablet; it works at very small amounts, so a low absorbed fraction is enough.
The category decides how a drug is made, how it is taken and which FDA pathway approves it.
| Small molecule | Peptide | Protein (biologic) | |
|---|---|---|---|
| Size | Under about 900 Da | About 500 to 5,000 Da, 2 to 40 amino acids | Over 40 amino acids, often 20,000 to 150,000 Da |
| Example | Aspirin, metformin, orforglipron | Oxytocin, semaglutide, tirzepatide | Insulin, growth hormone, antibodies |
| How it is made | Chemical synthesis | Chemical synthesis, or grown in yeast or bacteria | Grown in living cells |
| Shape | Fixed, rigid | Flexible chain, sometimes a ring | Folds into a 3D structure it needs to work |
| Swallowed as a pill | Usually works | Usually digested; a few exceptions | Digested |
| Where it acts | Can enter cells | Mostly receptors on the cell surface | Cell surface or in the blood |
| US approval route | New drug application | New drug application | Biologics license application |
| Copies after patent | Generics | Generics (synthetic) | Biosimilars |
Orforglipron (Foundayo), approved in April 2026, is a GLP-1 drug that is not a peptide. It is a small molecule designed to activate the same receptor, which is why it can be taken as a pill without an absorption enhancer.
"Peptides are natural, so they are safe."
What the evidence saysInsulin is a natural peptide and an overdose can kill. Safety depends on the specific molecule, the amount, the purity of the product and who is taking it. Being made of amino acids does not lower any of those risks.
"It worked in rats, so it works."
What the evidence saysMost peptides sold for healing, longevity and cognition have little or no randomized human data. Our guide to reading peptide research explains why animal results so often fail to hold up in people.
"A peptide capsule works like the injection."
What the evidence saysWithout a special absorption enhancer, almost none of a swallowed peptide reaches the blood. Even oral semaglutide, which has one, absorbs only about 0.4 to 1% of what is in the tablet.
Trial readouts, label changes and FDA actions on peptides, in plain language. Weekly, free, and we never sell peptides.